Candel Therapeutics Inc
CADL
Get informed when a big investor buys or sells
+ FollowMarket Cap$455.68M
Close$
$2.22
76% downside
Current Fair Value
76% downsideOvervalued by 76% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $455.68 Million |
|---|---|
| Enterprise Value | $262.71 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.72 |
| Beta | -0.59 |
| Outstanding Shares | 62,361,897 |
Return
| Return on Equity | -9.89% |
|---|---|
| Return on Assets | -6.76% |
| Return on Invested Capital | -25.56% |
Valuation & Multiples
| P/E Ratio | -9.51 |
|---|---|
| PEG | 4.32 |
| Price to Sales | - |
| Price to Book Ratio | 4.64 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.27 |
| Enterprise Value to Net Income | -20 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3799▲ 3.40% |
|---|---|
| Total Calls | 371,700▲ 36.20% |
| Total Puts | 141,200▲ 49.58% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 82.01%▲ 38.95% |
|---|---|
| Total Invested | $212.92M▲ 59.48% |
| Investors Holding | 118▲ 30.00% |
ESG Score
No data
About Candel Therapeutics Inc
2,021 employees